• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于不对称多相催化的网状结晶多孔材料

Reticulating Crystalline Porous Materials for Asymmetric Heterogeneous Catalysis.

作者信息

Han Xing, Li Weiwei, Yang Bolinyishi, Jiang Chao, Qu Zan, Xu Haomiao, Liu Yan, Cui Yong

机构信息

School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.

School of Chemistry and Chemical Engineering and State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, 200240, China.

出版信息

Adv Mater. 2024 Dec 30:e2415574. doi: 10.1002/adma.202415574.

DOI:10.1002/adma.202415574
PMID:39740186
Abstract

Asymmetric catalysis is essential for addressing the increasing demand for enantiopure compounds. Recent advances in reticular chemistry have demonstrated that metal-organic frameworks (MOFs) and covalent organic frameworks (COFs) possess highly regular porous architectures, exceptional tunability, and the ability to incorporate chiral functionalities through their open channels or cavities. These characteristics make them highly effective and enantioselective catalysts for a wide range of asymmetric transformations. The chiral microenvironments within these frameworks facilitate precise control over reactant orientation and transition states, enhancing both catalytic activity and enantioselectivity, thereby offering significant advantages over traditional systems. This review overviews recent developments in chiral MOFs (CMOFs) and chiral COFs (CCOFs), focusing on their design strategies, and synthetic methods, and highlights the structure-property relationships that connect key structural features to asymmetric catalytic performance. Additionally, the current challenges and future prospects in this field are addressed, highlighting the pivotal role of reticular chemistry in the creation of chiral porous materials. It is anticipated that this review will inspire further research into the application of crystalline porous materials in asymmetric catalysis and promote the rational design of novel chiral heterogeneous catalysts for industrial use.

摘要

不对称催化对于满足对映体纯化合物日益增长的需求至关重要。网状化学的最新进展表明,金属有机框架(MOF)和共价有机框架(COF)具有高度规则的多孔结构、出色的可调性,以及通过其开放通道或空腔引入手性功能的能力。这些特性使其成为广泛不对称转化的高效对映选择性催化剂。这些框架内的手性微环境有助于精确控制反应物的取向和过渡态,提高催化活性和对映选择性,从而比传统体系具有显著优势。本综述概述了手性MOF(CMOF)和手性COF(CCOF)的最新进展,重点介绍了它们的设计策略和合成方法,并强调了将关键结构特征与不对称催化性能联系起来的结构-性能关系。此外,还讨论了该领域当前的挑战和未来前景,突出了网状化学在创建手性多孔材料中的关键作用。预计本综述将激发对结晶多孔材料在不对称催化中应用的进一步研究,并促进用于工业用途的新型手性多相催化剂的合理设计。

相似文献

1
Reticulating Crystalline Porous Materials for Asymmetric Heterogeneous Catalysis.用于不对称多相催化的网状结晶多孔材料
Adv Mater. 2024 Dec 30:e2415574. doi: 10.1002/adma.202415574.
2
Advances in Chiral Metal-Organic and Covalent Organic Frameworks for Asymmetric Catalysis.用于不对称催化的手性金属有机框架和共价有机框架的进展
Small. 2021 Jun;17(22):e2005686. doi: 10.1002/smll.202005686. Epub 2021 Mar 18.
3
Covalent Metal-Organic Frameworks: Fusion of Covalent Organic Frameworks and Metal-Organic Frameworks.共价金属有机框架:共价有机框架与金属有机框架的融合
Acc Chem Res. 2025 Mar 4;58(5):746-761. doi: 10.1021/acs.accounts.4c00774. Epub 2025 Feb 21.
4
Recent Advances in the Utilization of Chiral Covalent Organic Frameworks for Asymmetric Photocatalysis.用于不对称光催化的手性共价有机框架的利用研究进展
Molecules. 2024 Oct 23;29(21):5006. doi: 10.3390/molecules29215006.
5
Asymmetric Catalysis within the Chiral Confined Space of Metal-Organic Architectures.手性金属-有机骨架中的不对称催化作用。
Small. 2019 Aug;15(32):e1804770. doi: 10.1002/smll.201804770. Epub 2019 Feb 4.
6
Chiral covalent organic frameworks: design, synthesis and property.手性共价有机框架:设计、合成与性质
Chem Soc Rev. 2020 Sep 1;49(17):6248-6272. doi: 10.1039/d0cs00009d.
7
Challenges and opportunities for chiral covalent organic frameworks.手性共价有机框架面临的挑战与机遇
Chem Sci. 2022 Jul 20;13(34):9811-9832. doi: 10.1039/d2sc02436e. eCollection 2022 Aug 31.
8
The Application of Covalent Organic Frameworks for Chiral Chemistry.共价有机框架在手性化学中的应用。
Macromol Rapid Commun. 2020 Oct;41(20):e2000404. doi: 10.1002/marc.202000404. Epub 2020 Sep 16.
9
Recent progress in the design, synthesis and applications of chiral metal-organic frameworks.手性金属有机框架材料的设计、合成及应用的最新进展
Front Chem. 2022 Oct 5;10:1014248. doi: 10.3389/fchem.2022.1014248. eCollection 2022.
10
Homochiral 2D Porous Covalent Organic Frameworks for Heterogeneous Asymmetric Catalysis.手性二维多孔共价有机框架用于多相不对称催化。
J Am Chem Soc. 2016 Sep 28;138(38):12332-5. doi: 10.1021/jacs.6b07714. Epub 2016 Sep 20.

引用本文的文献

1
DiffCoRank: a comprehensive framework for discovering hub genes and differential gene co-expression in brain implant-associated tissue responses.DiffCoRank:用于发现脑植入相关组织反应中的枢纽基因和差异基因共表达的综合框架。
BMC Bioinformatics. 2025 Jul 23;26(1):191. doi: 10.1186/s12859-025-06232-y.
2
Symmetry Breaking of Molecules Triggered by Chiral Inorganic Nanostructures Without Organic Components.无有机成分的手性无机纳米结构引发的分子对称性破缺
Adv Sci (Weinh). 2025 Aug;12(32):e04269. doi: 10.1002/advs.202504269. Epub 2025 Jun 20.
3
Cx43 mediates cross-talk of tumor cells and macrophage via cGAS-STING signaling.
Cx43通过cGAS-STING信号通路介导肿瘤细胞与巨噬细胞之间的相互作用。
Med Oncol. 2025 May 28;42(7):223. doi: 10.1007/s12032-025-02773-7.
4
Microneedle-aided nanotherapeutics delivery and nanosensor intervention in advanced tissue regeneration.微针辅助纳米治疗递送与纳米传感器在高级组织再生中的干预
J Nanobiotechnology. 2025 May 3;23(1):330. doi: 10.1186/s12951-025-03383-1.
5
From design to efficiency: cobalt-based MOFs for efficient and stable electrocatalysis in hydrogen and oxygen evolution reactions.从设计到效率:用于析氢和析氧反应中高效稳定电催化的钴基金属有机框架材料
RSC Adv. 2025 Mar 18;15(11):8420-8429. doi: 10.1039/d5ra00286a. eCollection 2025 Mar 17.
6
A prospective diagnostic model for breast cancer utilizing machine learning to examine the molecular immune infiltrate in HSPB6.利用机器学习分析 HSPB6 中分子免疫浸润物的乳腺癌前瞻性诊断模型。
J Cancer Res Clin Oncol. 2024 Oct 23;150(10):475. doi: 10.1007/s00432-024-05995-w.